TG Therapeutics Inc (TGTX.OQ)

TGTX.OQ on NASDAQ Stock Exchange Capital Market

15.48USD
31 Mar 2015
Change (% chg)

$-0.68 (-4.21%)
Prev Close
$16.16
Open
$16.00
Day's High
$16.32
Day's Low
$15.46
Volume
180,136
Avg. Vol
182,220
52-wk High
$20.00
52-wk Low
$4.43

TGTX.OQ

Chart for TGTX.OQ

About

TG Therapeutics, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. The Company is developing two therapies targeting hematological malignancies. TG-1101 (ublituximab) is a chimeric,... (more)

Overall

Beta: 1.84
Market Cap(Mil.): $752.15
Shares Outstanding(Mil.): 46.54
Dividend: --
Yield (%): --

Financials

  TGTX.OQ Industry Sector
P/E (TTM): -- 136.15 41.01
EPS (TTM): -1.61 -- --
ROI: -90.39 -0.91 16.17
ROE: -92.85 -2.73 17.02
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks